Albert D Mason Inc Novartis Ag Transaction History

Albert D Mason Inc

  • $123 Million
  • Q1 2025

A detailed history of Albert D Mason Inc transactions in Novartis Ag stock. As of the latest transaction made, Albert D Mason Inc holds 26,028 shares of NVS stock, worth $2.91 Million. This represents 2.37% of its overall portfolio holdings.

Number of Shares
26,028
Previous 13,254 96.38%
Holding current value
$2.91 Million
Previous $1.29 Million 125.06%
% of portfolio
2.37%
Previous 1.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 16, 2025
BUY
$97.14 - $115.57 $1.24 Million - $1.48 Million
12,774 Added 96.38%
26,028 $2.9 Million
Q4 2024

Jan 15, 2025
SELL
$96.78 - $117.18 $21,581 - $26,131
-223 Reduced 1.65%
13,254 $1.29 Million
Q3 2024

Oct 22, 2024
SELL
$106.13 - $120.89 $7,853 - $8,945
-74 Reduced 0.55%
13,477 $1.55 Million
Q2 2024

Jul 16, 2024
BUY
$92.57 - $107.37 $5,831 - $6,764
63 Added 0.47%
13,551 $1.44 Million
Q1 2024

Apr 24, 2024
BUY
$95.27 - $108.47 $1,619 - $1,843
17 Added 0.13%
13,488 $1.31 Million
Q4 2023

Jan 03, 2024
SELL
$92.27 - $101.54 $2,768 - $3,046
-30 Reduced 0.22%
13,471 $1.36 Million
Q3 2023

Oct 10, 2023
SELL
$94.73 - $105.13 $140,200 - $155,592
-1,480 Reduced 9.88%
13,501 $1.38 Million
Q2 2023

Jul 25, 2023
SELL
$92.52 - $104.91 $40,431 - $45,845
-437 Reduced 2.83%
14,981 $1.51 Million
Q1 2023

Apr 11, 2023
SELL
$80.03 - $92.81 $5,121 - $5,939
-64 Reduced 0.41%
15,418 $1.42 Million
Q4 2022

Jan 11, 2023
SELL
$75.55 - $92.52 $1,737 - $2,127
-23 Reduced 0.15%
15,482 $1.41 Million
Q3 2022

Oct 12, 2022
BUY
$74.61 - $87.26 $6,714 - $7,853
90 Added 0.58%
15,505 $1.18 Million
Q2 2022

Jul 12, 2022
BUY
$80.52 - $93.75 $1,368 - $1,593
17 Added 0.11%
15,415 $1.3 Million
Q1 2022

Apr 20, 2022
SELL
$80.11 - $90.62 $23,552 - $26,642
-294 Reduced 1.87%
15,398 $1.35 Million
Q4 2021

Jan 25, 2022
BUY
$79.7 - $88.13 $198,771 - $219,796
2,494 Added 18.9%
15,692 $1.37 Million
Q3 2021

Oct 13, 2021
BUY
$81.78 - $95.14 $3,107 - $3,615
38 Added 0.29%
13,198 $1.08 Million
Q2 2021

Jul 14, 2021
SELL
$85.24 - $94.15 $36,653 - $40,484
-430 Reduced 3.16%
13,160 $1.2 Million
Q1 2021

Apr 14, 2021
SELL
$83.5 - $98.47 $11,272 - $13,293
-135 Reduced 0.98%
13,590 $1.16 Million
Q4 2020

Jan 12, 2021
BUY
$78.07 - $94.43 $11,398 - $13,786
146 Added 1.08%
13,725 $1.3 Million
Q3 2020

Oct 20, 2020
BUY
$82.14 - $91.0 $18,481 - $20,475
225 Added 1.68%
13,579 $1.18 Million
Q2 2020

Jul 21, 2020
SELL
$80.93 - $91.1 $5,665 - $6,377
-70 Reduced 0.52%
13,354 $1.17 Million
Q1 2020

Apr 15, 2020
BUY
$70.67 - $99.01 $3,180 - $4,455
45 Added 0.34%
13,424 $1.11 Million
Q4 2019

Jan 21, 2020
BUY
$84.35 - $95.37 $18,978 - $21,458
225 Added 1.71%
13,379 $1.27 Million
Q3 2019

Oct 23, 2019
BUY
$85.54 - $94.26 $3,849 - $4,241
45 Added 0.34%
13,154 $1.14 Million
Q2 2019

Jul 30, 2019
SELL
$75.4 - $92.8 $5,278 - $6,496
-70 Reduced 0.53%
13,109 $1.2 Million
Q1 2019

Apr 30, 2019
BUY
$75.32 - $86.15 $10,544 - $12,061
140 Added 1.07%
13,179 $1.27 Million
Q4 2018

Jan 29, 2019
SELL
$73.66 - $82.02 $5,524 - $6,151
-75 Reduced 0.57%
13,039 $1.12 Million
Q3 2018

Oct 30, 2018
BUY
$66.94 - $77.43 $168,354 - $194,736
2,515 Added 23.73%
13,114 $1.13 Million
Q2 2018

Jul 31, 2018
BUY
$64.91 - $73.36 $155,784 - $176,064
2,400 Added 29.27%
10,599 $801,000
Q1 2018

May 02, 2018
SELL
$70.39 - $84.15 $2,463 - $2,945
-35 Reduced 0.43%
8,199 $663,000
Q4 2017

Feb 06, 2018
BUY
$72.33 - $77.64 $1,808 - $1,941
25 Added 0.3%
8,234 $691,000
Q3 2017

Oct 18, 2017
BUY
$74.14 - $77.27 $608,615 - $634,309
8,209
8,209 $705,000

Others Institutions Holding NVS

# of Institutions
1,524
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $241B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Albert D Mason Inc Portfolio

Follow Albert D Mason Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Albert D Mason Inc, based on Form 13F filings with the SEC.

News

Stay updated on Albert D Mason Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email